CALIFORNIA: Revolution Medicines said on April 13 that its experimental pancreatic cancer drug daraxonrasib significantly extended survival in a pivotal late-stage trial, marking one of the strongest reported results to date for a targeted medicine…
MAINE: Maine’s tourism industry is contending with a prolonged drop in Canadian travel to the United States, a trend that has extended into early 2026 and is weighing on one of the state’s…
